Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Surgery for Pulmonary Fungal Infections Complicating Hematological Malignancies

  • Yamamichi, Takashi (Department of General Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital) ;
  • Horio, Hirotoshi (Department of General Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital) ;
  • Asakawa, Ayaka (Department of General Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital) ;
  • Okui, Masayuki (Department of General Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital) ;
  • Harada, Masahiko (Department of General Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital)
  • Received : 2018.06.19
  • Accepted : 2018.07.18
  • Published : 2018.10.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The complication rate of fungal disease is higher among patients with hematological malignancies. We investigated the clinicobacteriological outcomes of resected pulmonary fungal infections complicating hematological malignancies. Methods: Between 2001 and 2017, 21 patients with pulmonary fungal infections complicating hematological malignancies underwent resection, and their clinical records and survival were retrospectively reviewed. Results: The median age of the patients was 47 years, and 13 were male. The histological diagnoses were pulmonary aspergillosis (19 cases), mucormycosis (1 case), and cryptococcosis (1 case). The indications for surgery were resistance to antifungal therapy and the necessity of surgery before hematopoietic stem cell transplantation in 13 and 8 cases, respectively. The diagnoses of the hematological malignancies were acute myelogenous leukemia (10 cases), acute lymphocytic leukemia (5 cases), myelodysplastic syndrome (3 cases), and chronic myelogenous leukemia, malignant lymphoma, and extramedullary plasmacytoma (1 case each). The surgical procedures were partial resection (11 cases), segmentectomy (5 cases), lobectomy (4 cases), and cavernostomy (1 case). The size of the lesions was 0.9-8.5 cm. Fourteen cases had cavitation. There were no surgical-related deaths or fungal progression. Conclusion: Pulmonary fungal infections are resistant to treatments for hematological malignancies. Since the treatment of the underlying disease is extended and these infections often recur and are exacerbated, surgery should be considered when possible.

Keywords

References

  1. Hamaji M, Cassivi SD, Shen KR, et al. The outcome of pulmonary resection for invasive fungal infection complicating haematological malignancy. Eur J Cardiothorac Surg 2014;45:e1-5. https://doi.org/10.1093/ejcts/ezt483
  2. Wu GX, Khojabekyan M, Wang J, et al. Survival following lung resection in immunocompromised patients with pulmonary invasive fungal infection. Eur J Cardiothorac Surg 2016;49:314-20. https://doi.org/10.1093/ejcts/ezv026
  3. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006;91: 1068-75.
  4. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010;50:1091-100. https://doi.org/10.1086/651263
  5. Even C, Bastuji-Garin S, Hicheri Y, et al. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study. Haematologica 2011;96: 337-41. https://doi.org/10.3324/haematol.2010.030825
  6. Pagano L, Caira M, Candoni A, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 2010;95:644-50. https://doi.org/10.3324/haematol.2009.012054
  7. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001;19: 253-9. https://doi.org/10.1200/JCO.2001.19.1.253
  8. Shi JM, Cai Z, Huang H, et al. Role of CT-guided percuta- neous lung biopsy in diagnosis of pulmonary fungal infection in patients with hematologic diseases. Int J Hematol 2009;89:624-7. https://doi.org/10.1007/s12185-009-0351-0
  9. Lass-Florl C, Resch G, Nachbaur D, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 2007;45:e101-4. https://doi.org/10.1086/521245
  10. Nebiker CA, Lardinois D, Junker L, et al. Lung resection in hematologic patients with pulmonary invasive fungal disease. Chest 2012;142:988-95. https://doi.org/10.1378/chest.11-1964
  11. Segal BH. Aspergillosis. N Engl J Med 2009;360:1870-84. https://doi.org/10.1056/NEJMra0808853
  12. Theodore S, Liava'a M, Antippa P, et al. Surgical management of invasive pulmonary fungal infection in hematol- ogy patients. Ann Thorac Surg 2009;87:1532-8. https://doi.org/10.1016/j.athoracsur.2009.02.069
  13. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of as- pergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46: 327-60. https://doi.org/10.1086/525258

Cited by

  1. Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) vol.63, pp.7, 2018, https://doi.org/10.1111/myc.13082